These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16163661)

  • 1. [The direct cost of epilepsy in Cuba. A study in outpatients].
    González-Pal S; Quintana Mendoza J; Román López JR; Fernández-Pérez JE
    Rev Neurol; 2005 Sep 16-30; 41(6):379-81. PubMed ID: 16163661
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
    Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R
    Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the cost of epilepsy in Europe: a review with economic modeling.
    Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
    Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
    Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
    Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary care treatment of epilepsy with phenobarbital in rural China: cost-outcome analysis from the WHO/ILAE/IBE global campaign against epilepsy demonstration project.
    Ding D; Hong Z; Chen GS; Dai XY; Wu JZ; Wang WZ; De Boer HM; Sander JW; Prilipko L; Chisholm D
    Epilepsia; 2008 Mar; 49(3):535-9. PubMed ID: 18302628
    [No Abstract]   [Full Text] [Related]  

  • 6. [The costs of epilepsy in Germany].
    Dodel R; Rosenow F; Hamer HM
    Pharm Unserer Zeit; 2007; 36(4):298-305. PubMed ID: 17623320
    [No Abstract]   [Full Text] [Related]  

  • 7. Driving cost factors in adult outpatients with refractory epilepsy: a daily clinical practice in clinics of neurology in Spain.
    Peña P; Sancho J; Rufo M; Martínez S; Rejas J;
    Epilepsy Res; 2009 Feb; 83(2-3):133-43. PubMed ID: 19095410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy.
    Ettinger AB; Manjunath R; Candrilli SD; Davis KL
    Epilepsy Behav; 2009 Feb; 14(2):324-9. PubMed ID: 19028602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
    Davis KL; Candrilli SD; Edin HM
    Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct medical cost of children and adolescents epilepsy at a university setting in Croatia.
    Prpić I; Boban M; Skarpa-Prpić I; Jurjević A; Babić T; Fiket D
    Coll Antropol; 2009 Jun; 33(2):503-8. PubMed ID: 19662770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health and non-health care resources use in the management of adult outpatients with drug-resistant epilepsy in Spain: a cost-of-illness study (LINCE study).
    Sancho J; Peña P; Rufo M; Palacios G; Masramon X; Rejas J;
    Epilepsy Res; 2008 Oct; 81(2-3):176-87. PubMed ID: 18617369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. World-wide disparities in epilepsy care: a Latin American outlook.
    Fandiño-Franky J; Silfvenius H
    Epilepsia; 1999; 40 Suppl 8():48-54. PubMed ID: 10563596
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
    Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
    Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vision for the future.
    Beran R; Pachlatko C
    Epilepsia; 1999; 40 Suppl 8():55-6. PubMed ID: 10563597
    [No Abstract]   [Full Text] [Related]  

  • 15. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
    Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
    Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The direct costs of epilepsy in a Chilean population].
    Mesa T; Mesa JT; Guarda J; Mahaluf F; Pauchard F; Undurraga F; Asmad C; Silva G
    Rev Neurol; 2007 Jun 16-30; 44(12):710-4. PubMed ID: 17583862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considering economic reality in calculating the financial burden of epilepsy in China.
    Li L; Li J; Wu X; Zhu Y; Lei D
    Epilepsia; 2011 Feb; 52(2):416-8. PubMed ID: 21314681
    [No Abstract]   [Full Text] [Related]  

  • 18. The cost of epilepsy care to the community.
    Pachlatko C
    Seizure; 1997 Dec; 6(6):415-7. PubMed ID: 9530935
    [No Abstract]   [Full Text] [Related]  

  • 19. Report of the International League Against Epilepsy Commission on economic aspects of epilepsy.
    Beran RG; Pachlatko C
    Epilepsia; 1996 May; 37(5):506-8. PubMed ID: 8617183
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct medical costs for patients seeking emergency care for losses of epilepsy control in a U.S. managed care setting.
    Zachry WM; Doan QD; Smith BJ; Clewell JD; Griffith JM
    Epilepsy Behav; 2009 Oct; 16(2):268-73. PubMed ID: 19747882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.